作者:Bao-Min Xi、Pei-Zhou Ni、Zhen-Zhou Jiang、Dian-Qing Wu、Shou-Hua Zhang、Hui-Bin Zhang、Tao Wang、Wen-Hua Chen
DOI:10.1111/j.1747-0285.2010.01040.x
日期:2010.12
Finding effective chemotherapeutic agents for clinical use is a long‐lasting goal in medicinal chemistry. In this study, we report a new class of α1‐adrenoceptor (α1‐AR) antagonists. Specifically, we describe the synthesis and the blocking activities toward α1‐AR of 7‐(2‐hydroxypropoxy)‐3,4‐dihydroisoquinolin‐1(2H)‐one 1 and its structurally perturbed analogs 2–11 that were designed according to the principle of bioisosterism. Their structures were identified with IR, 1H NMR, MS, HRMS and elemental analysis. The blocking activities of compounds 1–11 were evaluated on isolated rat anococcygeus muscles. The results indicated that these compounds showed moderate to good activities. Among them, compound 1 exhibited the highest activity that was comparable to those of known α1‐AR antagonists tamsulosin and DDPH (1‐(2,6‐dimethylphenoxy)‐2‐(3,4‐di‐ methoxyphenylethylamino)propane hydrochloride) and thus may be exploitable as a lead compound for the discovery of promising α1‐AR antagonists.